Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -21.79%410.37M | 3.67%1.07B | 25.50%524.73M | -25.28%1.04B | -39.54%418.09M | 2.73%1.39B | 45.09%691.55M | 71.32%1.35B | 81.82%476.63M | -3.37%788.01M |
| Operating income | -21.79%410.37M | 3.67%1.07B | 25.50%524.73M | -25.28%1.04B | -39.54%418.09M | 2.73%1.39B | 45.09%691.55M | 71.32%1.35B | 81.82%476.63M | -3.37%788.01M |
| Cost of sales | 20.12%-45.43M | 18.31%-108.4M | -20.65%-56.88M | 44.83%-132.7M | 58.36%-47.14M | 1.77%-240.54M | -95.57%-113.22M | -120.98%-244.88M | -88.40%-57.89M | -1.11%-110.81M |
| Operating expenses | 20.12%-45.43M | 18.31%-108.4M | -20.65%-56.88M | 44.83%-132.7M | 58.36%-47.14M | 1.77%-240.54M | -95.57%-113.22M | -120.98%-244.88M | -88.40%-57.89M | -1.11%-110.81M |
| Gross profit | -22.00%364.94M | 6.89%965.85M | 26.12%467.85M | -21.17%903.57M | -35.86%370.95M | 3.72%1.15B | 38.11%578.34M | 63.19%1.11B | 80.95%418.74M | -4.07%677.2M |
| Employee expense | 4.59%-251.81M | 0.31%-533.47M | -3.15%-263.91M | -14.10%-535.15M | -12.27%-255.86M | 13.23%-469.02M | 13.20%-227.9M | 2.36%-540.54M | -3.39%-262.54M | 20.04%-553.57M |
| Depreciation and amortization | 26.03%-92.05M | 23.95%-224.5M | 23.07%-124.45M | 39.80%-295.19M | 40.07%-161.76M | 16.84%-490.33M | 10.75%-269.93M | 4.98%-589.63M | -0.23%-302.45M | 5.29%-620.51M |
| Revaluation surplus | -600.27%-22.07M | -161.36%-39.1M | -47.33%4.41M | -16.28%63.73M | -79.54%8.38M | -32.52%76.12M | 220.97%40.93M | 132.84%112.81M | ---33.84M | -42.52%-343.5M |
| -Changes in the fair value of investment property | -600.27%-22.07M | -161.36%-39.1M | -47.33%4.41M | -16.28%63.73M | -79.54%8.38M | -32.52%76.12M | 220.97%40.93M | 132.84%112.81M | ---33.84M | -42.52%-343.5M |
| Impairment and provision | 1,993.90%4.03M | 51.56%-11.04M | 91.45%-213K | -141.87%-22.8M | -103.77%-2.49M | 113.64%54.45M | 151.26%66.17M | -13.19%-399.23M | -844.80%-129.09M | -94.46%-352.72M |
| -Impairment of intangible assets | ---- | ---- | ---- | -48.17%-12.94M | ---- | 97.81%-8.74M | ---- | ---398.45M | ---130.88M | ---- |
| -Goodwill impairment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---299.9M |
| -Other impairment is provision | 1,993.90%4.03M | -12.07%-11.04M | 91.45%-213K | -115.59%-9.85M | -103.77%-2.49M | 8,179.54%63.18M | 3,586.46%66.17M | 98.52%-782K | -89.64%1.8M | 70.88%-52.82M |
| Special items of operating profit | 21.57%-192.27M | 0.61%-519.92M | -2.78%-245.15M | -16.25%-523.12M | -12.38%-238.51M | 23.36%-449.98M | 0.31%-212.22M | 22.55%-587.15M | 44.74%-212.88M | 10.55%-758.14M |
| Operating profit | -11.26%-200.81M | 4.77%-399.65M | 36.09%-180.49M | -207.68%-419.67M | -985.40%-282.41M | 84.95%-136.4M | 95.05%-26.02M | 54.14%-906.07M | 25.66%-525.15M | -1.33%-1.98B |
| Financing cost | 14.64%-43.56M | 8.38%-94.44M | 8.13%-51.03M | -4.49%-103.08M | 1.23%-55.55M | 26.62%-98.65M | 16.98%-56.25M | -7.54%-134.44M | -11.07%-67.75M | 33.28%-125.02M |
| Earning before tax | -5.55%-244.37M | 5.48%-494.09M | 31.50%-231.52M | -122.40%-522.75M | -310.82%-337.96M | 77.41%-235.05M | 86.13%-82.27M | 50.46%-1.04B | 22.74%-592.9M | 1.71%-2.1B |
| Tax | -20.00%-24K | -118.12%-56K | 97.95%-20K | -98.30%309K | 95.77%-977K | 218.91%18.14M | 25.09%-23.09M | -5.58%-15.25M | -24.24%-30.83M | -448.04%-14.45M |
| After-tax profit from continuing operations | -5.55%-244.4M | 5.42%-494.14M | 31.69%-231.54M | -140.85%-522.44M | -221.70%-338.94M | 79.45%-216.91M | 83.11%-105.36M | 50.08%-1.06B | 21.27%-623.73M | 0.84%-2.12B |
| Earning after tax | -5.55%-244.4M | 5.42%-494.14M | 31.69%-231.54M | -140.85%-522.44M | -221.70%-338.94M | 79.45%-216.91M | 83.11%-105.36M | 50.08%-1.06B | 21.27%-623.73M | 0.84%-2.12B |
| Profit attributable to shareholders | -5.55%-244.4M | 5.42%-494.14M | 31.69%-231.54M | -140.85%-522.44M | -221.70%-338.94M | 79.45%-216.91M | 83.11%-105.36M | 50.08%-1.06B | 21.27%-623.73M | 0.84%-2.12B |
| Basic earnings per share | 64.80%-0.1606 | 55.02%-0.5154 | 38.63%-0.4562 | -2,133.72%-1.1459 | -2,885.54%-0.7434 | 80.89%-0.0513 | 85.49%-0.0249 | 57.59%-0.2684 | 31.55%-0.1716 | 12.92%-0.6328 |
| Diluted earnings per share | 64.80%-0.1606 | 55.02%-0.5154 | 38.63%-0.4562 | -2,133.72%-1.1459 | -2,885.54%-0.7434 | 80.89%-0.0513 | 85.49%-0.0249 | 57.59%-0.2684 | 31.55%-0.1716 | 12.92%-0.6328 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | -- | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | -- | Chengfeng Certified Public Accountants Limited | -- | Chengfeng Certified Public Accountants Limited | -- | Chengfeng Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.